Search Results

You are looking at 71 - 80 of 277 items for :

  • "lung cancer" x
Clear All
Magyar Sebészet
Authors: Ildikó Garai, Csaba Tóth, Lajos Szabados, Judit Sóvágó, Lajos Tóth and Zoltán Csiki

A Flint RL Wahl 2001 FDG uptake and expression of hexokinase II (HKII) and Glut-1 in untreated primary human non small cell lung cancer (NSCLC

Restricted access

Camus M, Siemiatycki J, Meek B 1998: Nonoccupational Exposure to Chrysotile Asbestos and the Risk of Lung Cancer. International Programme on Chemical Safety (IPCS), Vol. 338. CHAPD (Chemical Hazards and Poisons Division) 1995

Restricted access

Nafstad, P., Haheim, L. L., Oftedal, B., Gram, F., Holme, J., Hjermann, I., Leren, P.: Lung cancer and air pollution: a 27 year follow up of 16,209 Norwegian men. Thorax 58(12) , 1071-1076 (2003). Lung cancer and air pollution: a

Restricted access

2004 The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression Lung Cancer 46 283

Restricted access

endothelial progenitor cells in human non-small cell lung cancer Cancer Res 66 7341 7347 . 4. J Lövey

Restricted access
Interventional Medicine and Applied Science
Authors: Kamal Dua, Shakti Dhar Shukla, Terezinha de Jesus Andreoli Pinto and Philip Michael Hansbro

provides a new dimension to the pharmacotherapy and have cell-targeted drug delivery approach [ 4, 5 ], which is required in majority of the chronic respiratory conditions such as lung cancer, COPD, and pulmonary fibrosis. Advancements

Open access

523 548 Horvath I, Lazar Z, Gyulai N, Kollai M, Losonczy G: Exhaled biomarkers in lung cancer. Eur. Respir. J. 34, 261–275 (2009

Restricted access

therapy. J Clin Oncol. 2015; 33: 1974–1982. 5 Gálffy G. Actual issues in the immunotherapy of lung cancer. [A tüdőtumor immunterápiás kezelésének aktualitásai.] Onkol Hematol (olo.hu). 2018

Open access

, O. P., Taylor, P. R. (1996) α-Tocopherol and β-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of baseline characteristics and study compliance. J. Natl. Cancer Inst. 88 , 560

Restricted access

therapy in lung cancer Cancer Invest 6 139 43 . 6. V Matzi J

Restricted access